Thyroid and Bone Health: A Complex Relationship in Osteoporosis

David Ushaw^*
*Correspondence: David Ushaw, Department of Orthopedics and Rheumatology, Sechenov University, Moscow, Russia, Email:

Introduction

The thyroid gland plays a pivotal role in regulating metabolism, growth and development and its influence extends to bone health as well. Thyroid hormones, particularly Thyroxine (T4) and Triiodothyronine (T3), are critical for maintaining bone density and regulating bone remodeling. However, both an excess and a deficiency of thyroid hormones can disrupt the balance of bone resorption and formation, leading to conditions such as osteoporosis. Osteoporosis, characterized by weakened bones and an increased risk of fractures, is a condition that is often linked to thyroid dysfunction, particularly in individuals with untreated or poorly managed thyroid disorders. The relationship between thyroid hormones and bone health is complex. In conditions such as hyperthyroidism, where there is an overproduction of thyroid hormones, excessive bone resorption occurs, leading to decreased bone mineral density and an increased risk of fractures. Conversely, hypothyroidism, characterized by insufficient thyroid hormone production, can also have adverse effects on bones, leading to reduced bone formation and potentially contributing to osteoporotic changes over time. The dual impact of thyroid dysfunction on bone metabolism underscores the need for careful management of thyroid disorders to prevent or mitigate bone loss [1].

Description

The relationship between thyroid function and bone health is intricate and multifaceted, with thyroid hormones playing a crucial role in regulating bone metabolism. Both excess and deficiency of thyroid hormones can disrupt the delicate balance between bone resorption (breakdown) and bone formation, leading to conditions like osteoporosis, a disease characterized by weakened bones and an increased risk of fractures. Hyperthyroidism, where there is an overproduction of thyroid hormones, accelerates bone resorption by stimulating osteoclast activity, the cells responsible for breaking down bone tissue. This leads to a decrease in bone mineral density, making bones fragile and more prone to fractures. Over time, untreated or poorly managed hyperthyroidism can result in significant bone loss, particularly in weight-bearing bones like the spine, hips and wrists, which are most susceptible to fractures. On the other hand, hypothyroidism, a condition where thyroid hormone levels are insufficient, can also negatively impact bone health, although through a different mechanism. In hypothyroidism, the reduced levels of thyroid hormones lead to a decrease in bone turnover, which can result in decreased bone formation and impaired bone healing [2].

Thyroid function directly impacts bone metabolism, with both hypothyroidism and hyperthyroidism posing risks to bone health. While hypothyroidism may initially increase bone density, prolonged low thyroid hormone levels can lead to structural changes that weaken bones over time. In contrast, hyperthyroidism accelerates bone loss by increasing osteoclast activity, contributing to osteoporosis and an elevated fracture risk. The use of thyroid hormone replacement therapy in hypothyroid patients must be carefully monitored, as excessive doses can inadvertently induce hyperthyroidism and worsen bone loss. Maintaining balanced thyroid hormone levels is essential to prevent bone-related complications and support long-term skeletal health. The thyroid plays a critical role in bone health, with both hypothyroidism and hyperthyroidism having significant effects on bone density and strength [3].

In hypothyroidism, low thyroid hormone levels can lead to decreased bone turnover and increased bone mineral density in the short term. However, prolonged untreated hypothyroidism can result in the accumulation of organic matrix components within bone, which, over time, can disrupt bone structure and lead to an increased risk of fractures. Additionally, hypothyroidism is often associated with other conditions such as vitamin D deficiency or obesity, which can further impair bone health. Therefore, while the immediate effects of hypothyroidism may seem protective against bone loss, the long-term impact can be detrimental if left untreated. On the other hand, hyperthyroidism, characterized by excessive thyroid hormone production, is a well-established risk factor for osteoporosis and bone fragility. Elevated thyroid hormone levels increase bone resorption by stimulating osteoclast activity, leading to the breakdown of bone tissue and a reduction in bone density. This can result in an increased risk of fractures, particularly in postmenopausal women or individuals with pre-existing risk factors for osteoporosis. The relationship between thyroid function and bone health is further complicated by the use of thyroid hormone replacement therapy in individuals with hypothyroidism. If dosages are too high or not properly monitored, it can lead to subclinical hyperthyroidism, inadvertently increasing the risk of bone loss. Balancing thyroid hormone levels within the optimal range is crucial for maintaining bone health and preventing osteoporosis, underscoring the importance of regular monitoring and personalized treatment strategies in individuals with thyroid dysfunction [4].

While hypothyroidism is generally associated with decreased bone resorption, prolonged or untreated cases can contribute to osteoporotic changes and increased fracture risk, particularly in postmenopausal women, who are already at a higher risk for osteoporosis. The complex relationship between thyroid hormones and bone health highlights the importance of proper thyroid management in preventing bone loss. An imbalance in thyroid hormone levels whether from hyperthyroidism, hypothyroidism, or improper thyroid hormone treatment can lead to bone density issues and increase the risk of osteoporosis. Therefore, monitoring thyroid function and bone health together is essential for individuals with thyroid disorders, particularly those who are at higher risk for developing osteoporosis. Understanding the mechanisms through which thyroid hormones affect bone metabolism helps in the development of targeted prevention and treatment strategies for individuals with thyroid-related bone issues. These may include adjusting thyroid hormone treatment, using medications that protect bone health and promoting lifestyle modifications that support bone density, such as weight-bearing exercise and adequate calcium and vitamin D intake. As research continues, it is likely that more effective strategies for managing thyroid-related bone health will emerge, helping to reduce the impact of osteoporosis in this population [5].

Conclusion

In conclusion, the relationship between thyroid function and bone health is complex, with both hyperthyroidism and hypothyroidism contributing to the development of osteoporosis through different mechanisms. Hyperthyroidism accelerates bone resorption, leading to a decrease in bone density and an increased risk of fractures, while hypothyroidism can impair bone formation and potentially contribute to osteoporotic changes over time. Effective management of thyroid disorders is crucial for maintaining optimal bone health and preventing osteoporosis. By carefully monitoring thyroid hormone levels and bone density, clinicians can help mitigate the risk of bone loss in patients with thyroid dysfunction. As research progresses, a deeper understanding of the mechanisms linking thyroid hormones to bone metabolism will lead to more targeted prevention and treatment strategies, ultimately improving the quality of life for individuals at risk of osteoporosis.

Acknowledgment

None.

Conflict of Interest

None.

References

1. Sornay‐Rendu, Elisabeth, Françoise Munoz, François Duboeuf and Pierre D. Delmas. "Rate of forearm bone loss is associated with an increased risk of fracture independently of bone mass in postmenopausal women: The OFELY study." J Bone Min Res 20 (2005): 1929-1935.

   Google Scholar, Crossref, Indexed at

2. Konca Degertekin, Ceyla, Ozlem Turhan Iyidir, Banu Aktas Yılmaz and Sehri Elbeg, et al. "RANKL/osteoprotegerin system and bone turnover in hashimoto thyroiditis." Calcif Tissue Int 99 (2016): 365-372.

   Google Scholar, Crossref, Indexed at

3. Gaffney, Christopher D., Matthew J. Pagano, Adriana P. Kuker and Doron S. Stember, et al. "Osteoporosis and low bone mineral density in men with testosterone deficiency syndrome." Sex Med Rev 3 (2015): 298-315.

   Google Scholar, Crossref, Indexed at

4. Fidan, Nuri, Ayca Inci, Melahat Coban and Cevval Ulman, et al. "Bone mineral density and biochemical markers of bone metabolism in predialysis patients with chronic kidney disease." J Investig Med 64 (2016): 861-866.

   Google Scholar, Crossref, Indexed at

5. Mosekilde, L., F. Melsen and M. S. Christensen. "Interrelationships between bone morphometry, thyroid function tests and serum parathyroid hormone in hyperthyroidism." Calcif Tissue Res 22 (1976): 229-235.

   Google Scholar, Crossref, Indexed at